To further elucidate the molecular mechanism underlying the effect of ailanthone against HCC in vivo, we performed IHC analysis to investigate the protein expression of LC3, PINK1, PRKN, BAX, and BAK1 in tumour tissues. This evidence concerns the gene PINK1 and hepatocellular carcinoma.